PRECISION BIOSCIENCES INC — Director's Dealing 2026

Feb 19, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2026-02-17

Reporting Person: Kelly John Alexander (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-17	Common Stock	M	27584	—	Acquired	134032	Direct
2026-02-18	Common Stock	S	8149	$3.84	Disposed	125883	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-17	Restricted Stock Units	$	M	27584	Disposed		Common Stock (27584)	Direct

Footnotes

F1: Represents the vesting of Restricted Stock Units ("RSUs") on February 17, 2026.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: The sales were effected pursuant to a Rule 10b5-1 plan adopted on January 17, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F4: RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.